FORTIS

Fortis Healthcare Share Price

₹679.00 +21.2 (3.22%)

21 Nov, 2024 14:02

SIP TrendupStart SIP in FORTIS

Start SIP

Performance

  • Low
  • ₹655
  • High
  • ₹691
  • 52 Week Low
  • ₹356
  • 52 Week High
  • ₹691
  • Open Price₹655
  • Previous Close₹658
  • Volume4,649,592

Investment Returns

  • Over 1 Month + 10.75%
  • Over 3 Month + 27.67%
  • Over 6 Month + 49.11%
  • Over 1 Year + 87.24%
SIP Lightning

Smart Investing Starts Here Start SIP with Fortis Healthcare for Steady Growth!

Invest Now

Fortis Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 78.2
  • PEG Ratio
  • 4
  • Market Cap Cr
  • 51,262
  • P/B Ratio
  • 6
  • Average True Range
  • 20.65
  • EPS
  • 9.16
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 10.18
  • RSI
  • 64.37
  • MFI
  • 70.93

Fortis Healthcare Financials

Fortis Healthcare Technicals

EMA & SMA

Current Price
₹679.00
+ 21.2 (3.22%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹624.67
  • 50 Day
  • ₹600.71
  • 100 Day
  • ₹564.59
  • 200 Day
  • ₹511.25

Resistance and Support

654.93 Pivot Speed
  • R3 681.87
  • R2 671.93
  • R1 664.87
  • S1 647.87
  • S2 637.93
  • S3 630.87

What's your outlook on Fortis Healthcare?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Fortis Healthcare Limited, an IHH Healthcare Berhad Company, is a leading healthcare provider in India with 28 facilities, 4,500+ operational beds, and 400+ diagnostics centers. It offers comprehensive healthcare services across India, UAE, Nepal, and Sri Lanka.

Fortis Healthcare (Nse) has an operating revenue of Rs. 7,312.85 Cr. on a trailing 12-month basis. An annual revenue growth of 9% is good, Pre-tax margin of 12% is healthy, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 10%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 8% and 32% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 75 which is a FAIR score but needs to improve its earnings, a RS Rating of 79 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 30 indicates it belongs to a strong industry group of Medical-Hospitals and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock definitely has some strength, you may want to examine it in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Fortis Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-08 Quarterly Results
2024-10-09 Others Inter alia, to consider and approve the issue of Non-Convertible Debentures (NCD). per share(10%)Final Dividend
2024-08-30 To consider Fund Raising
2024-08-06 Quarterly Results
2024-05-23 Audited Results & Final Dividend
Date Purpose Remarks
2024-07-24 FINAL Rs.1.00 per share(10%)Final Dividend
2023-07-20 FINAL Rs.1.00 per share(10%)Final Dividend

Fortis Healthcare F&O

Fortis Healthcare Shareholding Pattern

31.17%
27.23%
2.2%
25.26%
1.19%
10.35%
2.6%

About Fortis Healthcare

  • NSE Symbol
  • FORTIS
  • BSE Symbol
  • 532843
  • Managing Director & CEO
  • Dr. Ashutosh Raghuvanshi
  • ISIN
  • INE061F01013

Similar Stocks to Fortis Healthcare

Fortis Healthcare FAQs

Fortis Healthcare share price is ₹679 As on 21 November, 2024 | 13:48

The Market Cap of Fortis Healthcare is ₹51261.7 Cr As on 21 November, 2024 | 13:48

The P/E ratio of Fortis Healthcare is 78.2 As on 21 November, 2024 | 13:48

The PB ratio of Fortis Healthcare is 6 As on 21 November, 2024 | 13:48

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23